MEI YEE WONG: Open Payments
NPI 1174150205 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,920 in 64 payments from 15 companies in 2025. Trend: 2023 $1,145 · 2024 $1,764 · 2025 $2,920
Food & beverage: $2,578Travel & lodging: $242Education: $99
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 8 | $570 |
| AstraZeneca Pharmaceuticals LP | 17 | $534 |
| Novo Nordisk Inc | 4 | $389 |
| Actelion Pharmaceuticals US, Inc. | 6 | $293 |
| Edwards Lifesciences Corporation | 2 | $176 |
| GlaxoSmithKline, LLC. | 3 | $159 |
| Boston Scientific Corporation | 1 | $158 |
| E.R. Squibb & Sons, L.L.C. | 13 | $157 |
| HEARTFLOW, INC. | 1 | $150 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $123 |
Products named: FARXIGA, Wegovy, UPTRAVI, FARAPULSE, FFRct, Ozempic, LOKELMA, AREXVY.
Industry payments across CA — which companies pay providers there.
